drugset / Trial / NCT02745223
Safety, Tolerability, and Efficacy of PresbiDrops (CSF-1), a Topical Ophthalmic Drug for Presbyopia
RandomizedCrossoverQuadruple-blindTreatment
Summary
A study to establish safety, tolerability, and efficacy of PresbiDrops (CSF-1) in presbyopic subjects.
Timeline
- Start
- 2016-07
- Primary completion
- 2017-06
- Completion
- 2017-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CILMOSTIM | Protein / enzyme biologic | — | Topical |